港股異動 | 被美列入特別指認國民名單持續發酵 中遠海能續跌逾7%
格隆匯10月2日丨中遠海能(1138.HK)繼上交易日大跌逾21%後,於今日至現價3.22港元再度跌7.2%,暫成交938.7萬港元,最新總市值129.8億股。公司上月29日公告稱,公司的直接全資附屬公司大連油運已被美國財政部海外資產控制辦公室(OFAC)列入特別指認國民名單(即OFAC公佈的被特別指認國民和被禁阻者名單 )。公司正全面梳理各項業務,評估相關影響,做好各項應對工作。中金研報指,目前無法確定制裁涉及的船舶範圍和對其的可能影響,暫維持公司A/H股跑贏行業評級和盈利預測不變。考慮到該事件直接影響投資者對公司的風險偏好,下調A/H股目標價至7.76元人民幣、4.8港幣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.